- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有43家主力机构披露2025-06-30报告期持股数据，持仓量总计1.19亿股，占流通A股23.05%
- 波段诊断：
-
技术面诊股
诊断结果：6.6技术面打败了62%的股票
技术面评分前10的股票
近期的平均成本为6.39元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为6.39元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.39","date":1760342296,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.10.14","stock":"0.16","trade":null,"ind":"-2.54"},{"date":"2025.10.13","stock":"-0.47","trade":null,"ind":"-0.93"},{"date":"2025.10.10","stock":"0.47","trade":null,"ind":"-2.70"},{"date":"2025.10.09","stock":"-0.78","trade":null,"ind":"1.47"},{"date":"2025.09.30","stock":"0.47","trade":null,"ind":"0.35"},{"date":"2025.09.29","stock":"0.47","trade":null,"ind":"2.05"},{"date":"2025.09.26","stock":"-0.47","trade":null,"ind":"-1.76"},{"date":"2025.09.25","stock":"-0.93","trade":null,"ind":"0.67"},{"date":"2025.09.24","stock":"1.26","trade":null,"ind":"1.80"},{"date":"2025.09.23","stock":"-1.55","trade":null,"ind":"-0.29"},{"date":"2025.09.22","stock":"-1.07","trade":null,"ind":"0.67"},{"date":"2025.09.19","stock":"-0.91","trade":null,"ind":"-0.04"},{"date":"2025.09.18","stock":"-1.94","trade":null,"ind":"-1.06"},{"date":"2025.09.17","stock":"-1.18","trade":null,"ind":"1.16"},{"date":"2025.09.16","stock":"0.74","trade":null,"ind":"0.45"},{"date":"2025.09.15","stock":"-0.44","trade":null,"ind":"0.63"},{"date":"2025.09.12","stock":"-0.29","trade":null,"ind":"-0.43"},{"date":"2025.09.11","stock":"0.74","trade":null,"ind":"3.36"},{"date":"2025.09.10","stock":"-0.15","trade":null,"ind":"0.38"},{"date":"2025.09.09","stock":"-1.89","trade":null,"ind":"-1.23"},{"date":"2025.09.08","stock":"2.38","trade":null,"ind":"0.61"}]
科华生物,深证成指,医疗器械指数
压力支撑
该股压力位为6.38元，支撑位为6.32元。
[{"text":"\u538b\u529b\u4f4d","value":"6.38","date":1760371200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.32","date":1760371200,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了35%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月14日 20:31
| 机构今日流向(万元) | -1120.81 | 机构5日流向(万元) | -2424.06 |
| 机构10日流向(万元) | -3440.79 | 机构20日流向(万元) | -14969.77 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少292.35万股，其中基金净减仓4家，主力净增仓10家，暂未发现中长期投资价值。
截止2025-06-30，共43家主力机构（基金38家，一般法人5家），持仓量总计11852.52万股，占流通A股23.05%
其中，基金持仓与2024-12-31相比：
增仓：7家 ，增持 13.60万股
减仓：11家 ，减持 17.14万股
新出现在主力名单中：20家 ，持有314.48万股
从主力名单中消失：10家 ，原持有287.82万股
其中，基金持仓与2024-12-31相比：
增仓：7家 ，增持 13.60万股
减仓：11家 ，减持 17.14万股
新出现在主力名单中：20家 ，持有314.48万股
从主力名单中消失：10家 ，原持有287.82万股
消息面诊股
诊断结果：5.3消息面打败了11%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 科华生物：公司2025年半年度已实现营业收入7.9
2025-09-30 - 科华生物：截至目前，公司股票不存在触及该项规定而被
2025-09-30 - 科华生物：公司将持续重点关注呼吸、消化和生殖等领域
2025-09-26 - 科华生物等成立医疗科技公司
2025-09-26 - 科华生物：公司采用直销与经销并存的销售模式，目前未
2025-09-26 - 科华生物：公司已搭建了丰富的产品矩阵，产品覆盖免疫
2025-09-26 - 科华生物：原财务总监罗芳女士辞职后将继续严格遵守《
2025-09-26 - 科华生物：公司合并报表内的部分子公司根据其公司章程
2025-09-26 - 科华生物：公司高度重视应收账款的管理工作
2025-09-25 - 聚焦区域医疗水平提升 | 科华生物与遵义医养集团签
2025-09-24
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-14 |
| 一般消息 | 募资投向 | 2025-09-17 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 高管变动 | 因退休 | 2025-07-31 |
| 重大利空 | 业绩预告 | 预计增亏 | 2025-07-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-28 |
| 一般消息 | 高管变动 | 个人原因 | 2025-03-16 |
| 重大利空 | 业绩预告 | 预计增亏 | 2025-01-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 2条 | 2条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了44%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.10.14","price":"-2.54","value":null},{"date":"2025.10.13","price":"-0.93","value":null},{"date":"2025.10.10","price":"-2.70","value":null},{"date":"2025.10.09","price":"1.47","value":null},{"date":"2025.09.30","price":"0.35","value":null},{"date":"2025.09.29","price":"2.05","value":null},{"date":"2025.09.26","price":"-1.76","value":null},{"date":"2025.09.25","price":"0.67","value":null},{"date":"2025.09.24","price":"1.80","value":null},{"date":"2025.09.23","price":"-0.29","value":null},{"date":"2025.09.22","price":"0.67","value":null},{"date":"2025.09.19","price":"-0.04","value":null},{"date":"2025.09.18","price":"-1.06","value":null},{"date":"2025.09.17","price":"1.16","value":null},{"date":"2025.09.16","price":"0.45","value":null},{"date":"2025.09.15","price":"0.63","value":null},{"date":"2025.09.12","price":"-0.43","value":null},{"date":"2025.09.11","price":"3.36","value":null},{"date":"2025.09.10","price":"0.38","value":null},{"date":"2025.09.09","price":"-1.23","value":null},{"date":"2025.09.08","price":"0.61","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 振德医疗 | 143.95% | 51.33% | 5.9分 |
| 2 | 英科医疗 | 19.99% | 19.40% | 6.5分 |
| 3 | - | 17.53% | 8.09% | 分 |
| 4 | 采纳股份 | 13.19% | 1.46% | 4.8分 |
| 5 | 海泰新光 | 13.10% | 5.52% | 6.2分 |
| 6 | 浩欧博 | 12.66% | -2.68% | 4.5分 |
| 8 | 康为世纪 | 8.61% | 2.52% | 5.0分 |
| 10 | 祥生医疗 | 6.26% | -0.33% | 6.2分 |
| 12 | 麦克奥迪 | 4.89% | -2.57% | 5.4分 |
| 14 | 福瑞股份 | 3.44% | -12.67% | 4.7分 |
| 16 | 九安医疗 | 0.71% | 3.36% | 5.7分 |
| 18 | 新华医疗 | -0.95% | 4.19% | 5.9分 |
| 20 | 可孚医疗 | -1.09% | 1.99% | 5.9分 |
| 22 | 黄山胶囊 | -1.43% | -0.52% | 6.2分 |
| 24 | 天臣医疗 | -1.63% | -5.83% | 5.2分 |
| 26 | 大博医疗 | -1.79% | 7.06% | 6.3分 |
| 28 | 东富龙 | -1.91% | 2.20% | 5.7分 |
| 30 | 港通医疗 | -2.47% | -0.97% | 5.5分 |
| 32 | 超研股份 | -2.86% | 2.20% | 5.4分 |
| 34 | 西山科技 | -3.11% | 2.20% | 5.3分 |
| 36 | 万孚生物 | -3.38% | 0.94% | 5.5分 |
| 38 | 奥泰生物 | -3.50% | -0.15% | 5.6分 |
| 40 | 山东药玻 | -3.66% | -0.14% | 5.5分 |
| 42 | 奥精医疗 | -3.80% | -5.63% | 4.5分 |
| 44 | 赛科希德 | -4.03% | -1.06% | 5.1分 |
| 46 | 爱威科技 | -4.23% | -0.12% | 5.8分 |
| 48 | 奕瑞科技 | -4.38% | -0.04% | 5.6分 |
| 50 | 南卫股份 | -4.65% | 0.82% | 5.7分 |
| 52 | 鱼跃医疗 | -5.15% | -1.72% | 5.6分 |
| 54 | 亚辉龙 | -5.28% | -0.14% | 5.3分 |
| 56 | 奥美医疗 | -5.67% | 2.22% | 6.3分 |
| 58 | 中红医疗 | -5.77% | 0.22% | 5.5分 |
| 60 | 基蛋生物 | -5.80% | -0.87% | 5.1分 |
| 62 | 心脉医疗 | -5.86% | -1.59% | 5.1分 |
| 64 | 威高血净 | -5.92% | 1.33% | 5.7分 |
| 66 | 正川股份 | -6.09% | -2.20% | 4.4分 |
| 68 | 康泰医学 | -6.37% | -1.48% | 4.6分 |
| 70 | 美康生物 | -6.51% | -0.97% | 4.6分 |
| 72 | 正海生物 | -6.69% | -0.25% | 4.7分 |
| 74 | 睿昂基因 | -7.04% | -0.57% | 5.4分 |
| 76 | 安必平 | -7.19% | -0.45% | 4.7分 |
| 78 | 东方生物 | -7.36% | -0.63% | 4.9分 |
| 80 | 科华生物 | -7.56% | -0.16% | 5.0分 |
| 82 | 澳华内镜 | -7.57% | -4.08% | 4.9分 |
| 84 | 蓝帆医疗 | -7.74% | 0.90% | 5.7分 |
| 86 | 国发股份 | -7.80% | 1.98% | 5.4分 |
| 88 | 尚荣医疗 | -7.96% | 0.00% | 4.9分 |
| 90 | 仁度生物 | -8.26% | -1.61% | 5.1分 |
| 92 | 山外山 | -8.39% | 4.19% | 6.1分 |
| 94 | 伟思医疗 | -8.51% | 0.16% | 5.4分 |
| 96 | 迈普医学 | -8.65% | -1.59% | 5.0分 |
| 98 | 春立医疗 | -8.89% | -4.09% | 5.6分 |
| 100 | 热景生物 | -9.27% | -5.94% | 4.3分 |
| 102 | 乐心医疗 | -9.42% | -1.27% | 5.3分 |
| 104 | 佰仁医疗 | -9.56% | -2.27% | 5.3分 |
| 106 | 三鑫医疗 | -10.01% | -0.44% | 5.3分 |
| 108 | 欧普康视 | -10.12% | -1.44% | 4.9分 |
| 110 | 冠昊生物 | -10.27% | -1.45% | 5.5分 |
| 112 | 康拓医疗 | -10.34% | -3.34% | 5.2分 |
| 114 | - | -11.01% | 5.98% | 分 |
| 116 | 赛诺医疗 | -11.51% | 3.34% | 5.1分 |
| 118 | 艾德生物 | -11.82% | -1.59% | 5.6分 |
| 120 | 瑞迈特 | -12.30% | -1.47% | 5.7分 |
| 122 | 安杰思 | -12.56% | -5.84% | 5.1分 |
| 124 | 爱博医疗 | -13.03% | -2.21% | 4.8分 |
| 126 | 康众医疗 | -13.80% | -4.39% | 4.8分 |
| 128 | 爱朋医疗 | -13.85% | -1.40% | 4.3分 |
| 130 | 威高骨科 | -14.40% | -6.08% | 5.3分 |
| 132 | - | -17.28% | 0.52% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 123/247 ， 96/247。
[{"date":"2025-06-30","value":"-4.05","vol":"2.27"},{"date":"2025-03-31","value":"-1.60","vol":"1.15"},{"date":"2024-12-31","value":"-17.03","vol":"0.53"},{"date":"2024-09-30","value":"-3.02","vol":"4.75"},{"date":"2024-06-30","value":"-1.28","vol":"3.53"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-4.05 | -1.60 | -17.03 | -3.02 | -1.28 |
| 行业(%) | 2.27 | 1.15 | 0.53 | 4.75 | 3.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"37.39","vol":"52.10"},{"date":"2025-03-31","value":"37.39","vol":"51.81"},{"date":"2024-12-31","value":"36.79","vol":"52.63"},{"date":"2024-09-30","value":"40.04","vol":"53.58"},{"date":"2024-06-30","value":"40.43","vol":"53.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
37.39 | 37.39 | 36.79 | 40.04 | 40.43 |
| 行业(%) | 52.10 | 51.81 | 52.63 | 53.58 | 53.70 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 92/247 ， 118/247。
[{"date":"2025-06-30","value":"-12.65","vol":"-1.71"},{"date":"2025-03-31","value":"-12.50","vol":"-0.92"},{"date":"2024-12-31","value":"-27.55","vol":"0.64"},{"date":"2024-09-30","value":"-29.09","vol":"0.79"},{"date":"2024-06-30","value":"-34.94","vol":"0.16"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-12.65 | -12.50 | -27.55 | -29.09 | -34.94 |
| 行业(%) | -1.71 | -0.92 | 0.64 | 0.79 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-154.37","vol":"-20.27"},{"date":"2025-03-31","value":"-84.79","vol":"-4.25"},{"date":"2024-12-31","value":"-173.74","vol":"-24.11"},{"date":"2024-09-30","value":"-512.11","vol":"-20.40"},{"date":"2024-06-30","value":"-348.31","vol":"8.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-154.37 | -84.79 | -173.74 | -512.11 | -348.31 |
| 行业(%) | -20.27 | -4.25 | -24.11 | -20.40 | 8.56 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/247 ， 100/247。
[{"date":"2025-06-30","value":"0.15","vol":"0.17"},{"date":"2025-03-31","value":"0.07","vol":"0.08"},{"date":"2024-12-31","value":"0.29","vol":"0.35"},{"date":"2024-09-30","value":"0.21","vol":"0.26"},{"date":"2024-06-30","value":"0.14","vol":"0.18"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.07 | 0.29 | 0.21 | 0.14 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.26 | 0.18 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.58","vol":"1.13"},{"date":"2025-03-31","value":"0.28","vol":"0.55"},{"date":"2024-12-31","value":"1.20","vol":"2.33"},{"date":"2024-09-30","value":"0.80","vol":"1.67"},{"date":"2024-06-30","value":"0.54","vol":"1.13"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.58 | 0.28 | 1.20 | 0.80 | 0.54 |
| 行业(次) | 1.13 | 0.55 | 2.33 | 1.67 | 1.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 100/247 ， 33/247。
[{"date":"2025-06-30","value":"0.07","vol":"15.06"},{"date":"2025-03-31","value":"-13.22","vol":"4.01"},{"date":"2024-12-31","value":"4.80","vol":"29.58"},{"date":"2024-09-30","value":"11.64","vol":"15.37"},{"date":"2024-06-30","value":"4.82","vol":"13.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 0.07 | -13.22 | 4.80 | 11.64 | 4.82 |
| 行业 | 15.06 | 4.01 | 29.58 | 15.37 | 13.04 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.57","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.98","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"0.98","vol":"2.31"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.57 | - | 0.98 | - | 0.98 |
| 行业 | 1.57 | 0.00 | 2.19 | 0.01 | 2.31 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 35/247 ， 30/247。
[{"date":"2025-06-30","value":"2.99","vol":"5.50"},{"date":"2025-03-31","value":"3.39","vol":"5.89"},{"date":"2024-12-31","value":"3.46","vol":"5.34"},{"date":"2024-09-30","value":"4.55","vol":"5.97"},{"date":"2024-06-30","value":"4.95","vol":"5.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.99 | 3.39 | 3.46 | 4.55 | 4.95 |
| 行业 | 5.50 | 5.89 | 5.34 | 5.97 | 5.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.83","vol":"4.40"},{"date":"2025-03-31","value":"2.05","vol":"4.77"},{"date":"2024-12-31","value":"2.15","vol":"4.32"},{"date":"2024-09-30","value":"2.81","vol":"4.82"},{"date":"2024-06-30","value":"3.44","vol":"4.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.83 | 2.05 | 2.15 | 2.81 | 3.44 |
| 行业 | 4.40 | 4.77 | 4.32 | 4.82 | 4.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 40/247 ， 34/247。
[{"date":"2025-06-30","value":"26.00","vol":"22.01"},{"date":"2025-03-31","value":"24.22","vol":"21.24"},{"date":"2024-12-31","value":"23.94","vol":"21.92"},{"date":"2024-09-30","value":"20.10","vol":"21.09"},{"date":"2024-06-30","value":"26.40","vol":"21.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
26.00 | 24.22 | 23.94 | 20.10 | 26.40 |
| 行业(%) | 22.01 | 21.24 | 21.92 | 21.09 | 21.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.42","vol":"0.58"},{"date":"2025-03-31","value":"0.38","vol":"0.57"},{"date":"2024-12-31","value":"0.37","vol":"0.55"},{"date":"2024-09-30","value":"0.30","vol":"0.38"},{"date":"2024-06-30","value":"0.43","vol":"0.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.42 | 0.38 | 0.37 | 0.30 | 0.43 |
| 行业(%) | 0.58 | 0.57 | 0.55 | 0.38 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"8.50","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"9.71","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-2.34","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-6.41","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]